Evidence map›Paper›PMID 26509556›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2016

Development of a bovine decellularized extracellular matrix-biomaterial for nucleus pulposus regeneration.

Svenja Illien-Jünger, Dillon D Sedaghatpour, Damien M Laudier, Andrew C Hecht, Sheeraz A Qureshi, James C Iatridis

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Development of biomaterials for bone tissue engineering based on bile acids.Journal of materials science. Materials in medicine · 2025
    Review
  5. Harnessing CRISPR potential for intervertebral disc regeneration strategies.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Stem cell therapy in discogenic back pain.Journal of spine surgery (Hong Kong) · 2019
    Review
  16. Article
  17. Fibrin-Genipin Hydrogel for Cartilage Tissue Engineering in Nasal Reconstruction.The Annals of otology, rhinology, and laryngology · 2019
    Article
  18. The future of disc surgery and regeneration.International orthopaedics · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Svenja Illien-JüngerLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
Dillon D SedaghatpourLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
Damien M LaudierLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
Andrew C HechtLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
Sheeraz A QureshiLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
James C IatridisLeni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York.
Icahn School of Medicine at Mount Sinai · US

Funding

Model of Human Disc Regeneration in the spectrum of Degenerative Disc DiseaseR01AR057397 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2011 to 2021
$5.1M
NIAMS NIH HHS R01 AR057397
6 · The paper itself

Abstract

Painful intervertebral disc (IVD) degeneration is a common cause for spinal surgery. There is a clinical need to develop injectable biomaterials capable of promoting IVD regeneration, yet many available biomaterials do not mimic the native extracellular matrix (ECM) or promote matrix production. This study aimed to develop a decellularized injectable bovine ECM material that maintains structural and compositional features of native tissue and promotes nucleus pulposus (NP) cell (NPC) and mesenchymal stem cell (MSC) adaption. Injectable decellularized ECM constructs were created using 3 NP tissue decellularization methods (con.A: sodium deoxycholate, con.B: sodium deoxycholate & sodium dodecyl sulfate, con.C: sodium deoxycholate, sodium dodecyl sulfate & TritonX-100) and evaluated for protein, microstructure, and for cell adaptation in 21 day human NPC and MSC culture experiments. Con.A was most efficient at DNA depletion, preserved best collagen microstructure and content, and maintained the highest glycosaminoglycan (GAG) content. NPCs in decellularized constructs of con.A&B demonstrated newly synthesized GAG production, which was apparent from "halos" of GAG staining surrounding seeded NPCs. Con.A also promoted MSC adaption with high cell viability and ECM production. The injectable decellularized NP biomaterial that used sodium deoxycholate without additional decellularization steps maintained native NP tissue structure and composition closest to natural ECM and promoted cellular adaptation of NP cells and MSCs. This natural decellularized biomaterial warrants further investigation for its potential as an injectable cell seeded supplement to augment NP replacement biomaterials and deliver NPCs or MSCs. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:876-888, 2016.

Indexed as

Extracellular MatrixRegenerationTissue ScaffoldsAnimalsCattleCell ProliferationCollagen Type IIGlycosaminoglycansHumansMesenchymal Stem CellsNucleus PulposusCollagen Type IIGlycosaminoglycansdecellularizationextracellular matrix biomaterialintervertebral discnucleus pulposus replacementtissue engineering

Identifiers

PMID26509556
PMCPMC4898647
OpenAlexW2191225761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.